bluebird bio (BLUE) Tops Q3 EPS by 1c

bluebird bio (NASDAQ: BLUE) reported Q3 EPS of ($0.66), $0.01 better than the analyst estimate of ($0.67). Revenue for the quarter came in at $12.39 million versus the consensus estimate of $13.56 million.

For earnings history and earnings-related data on bluebird bio (BLUE) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Stifel Reiterates Buy Rating on FedEx (FDX) Ahead of Q4 Earnings
• Assurant (AIZ) is Piper Sandler's Weekly Focus Idea